{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:26:18Z","timestamp":1784582778711,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.leukres.2007.01.021","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T11:17:53Z","timestamp":1175167073000},"page":"1031-1038","source":"Crossref","is-referenced-by-count":30,"title":["WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"Jan Jacques","family":"Michiels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"De Raeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konnie","family":"Hebeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zwi","family":"Berneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Schroyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.01.021_bib1","series-title":"WHO classification of tumours. Tumours of haematopoiesis and lymphoid tissues","first-page":"31","article-title":"WHO classification of the chronic myeloproliferative diseases (CMPD) polycythemia vera, chronic idiopathic myelofibrosis, essential thrombocythemia and CMPD unclassifiable","year":"2001"},{"key":"10.1016\/j.leukres.2007.01.021_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2141.1998.00529.x","article-title":"Should a platelet count of 600\u00d7109\/l be used as a diagnostic criterion in essential thrombocythemia? An analysis of the natural course including early stages","volume":"100","author":"Lengfelder","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2007.01.021_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-2006-942754","article-title":"The 2001 World Health Organization (WHO) and updated European clinical and pathological (ECP) criteria for the diagnosis, classification and staging of the Ph1-chromosome negative chronic myeloproliferative disorders (MPD)","volume":"32","author":"Michiels","year":"2006","journal-title":"Sem Thromb Hemostas"},{"key":"10.1016\/j.leukres.2007.01.021_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.21105","article-title":"Red cell mass and plasma volume measurements in polycythemia","volume":"104","author":"Sirhan","year":"2005","journal-title":"Cancer"},{"issue":"suppl. 1","key":"10.1016\/j.leukres.2007.01.021_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10428199609074366","article-title":"Diagnostic applications of haematopoietic progenitor culture techniques in polycythaemias and thrombocythaemias","volume":"22","author":"Westwood","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2007.01.021_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.thj.6200344","article-title":"Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera","volume":"5","author":"Dobo","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.leukres.2007.01.021_bib7","first-page":"1194","article-title":"Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis","author":"Mossuz","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.01.021_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-006-6272-7","article-title":"Oncogenic mechanisms in myeloproliferative disorders","author":"Delhommeau","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.leukres.2007.01.021_bib9","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 V617F mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"Passamonti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.01.021_bib10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.01.021_bib11","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera","volume":"108","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.01.021_bib12","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activation mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLOS Med"},{"key":"10.1016\/j.leukres.2007.01.021_bib13","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.01.021_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02982575","article-title":"Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera and idiopathic myelofibrosis (agnogenic myeloid metaplasia)","volume":"76","author":"Michiels","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2007.01.021_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0950-3536(98)80036-X","article-title":"The histopathology of chronic myeloproliferative diseases","volume":"11","author":"Georgii","year":"1998","journal-title":"Baili\u00e8re's Clin Haematol"},{"key":"10.1016\/j.leukres.2007.01.021_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10428190500331329","article-title":"A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders","volume":"47","author":"Thiele","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2007.01.021_bib17","first-page":"1128","article-title":"European consensus for grading of bone marrow fibrosis and assessment of cellularity in myeloproliferative disorders","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.01.021_bib18","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of essential thrombocythemia and relation of essential thrombocythemia to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2007.01.021_bib19","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with matked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.01.021_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.leu.2404069","article-title":"Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis","volume":"20","author":"James","year":"2006","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260700046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260700046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T14:51:34Z","timestamp":1546959094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521260700046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S014521260700046X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.01.021","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}